|
| Exchange Disseminated Time 30/01/2017 15:59:19 | Lincoln Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on February 09, 2017, to consider and approve the Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter ended on December 31, 2016.
In view of above, the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available. |
|
|